The human brain is composed of a great diversity of cell types, which are generated largely during embryonic development. *In vivo*, this process is virtually invariant: every embryo acquires the same compendium of cell types, organized into the same anatomical structures^[@R1]^. It is unclear, however, whether the same reproducibility is achievable outside the embryo.

Prior work has shown that a large variety of cell types characteristic of defined brain regions, including the cerebral cortex, can be generated *in vitro*, within human brain organoid and spheroid models derived from pluripotent stem cells^[@R3]--[@R14]^. However, few studies have attempted to quantify cellular composition across individual organoids, limiting our understanding of the degrees of reproducibility achievable within different organoid models.

Therefore, we established four distinct protocols for producing 3D brain organoids and spheroids: self-patterned whole-brain organoids^[@R3]^; patterned dorsal forebrain organoids (modified from ^[@R5]^); and patterned dorsal and ventral spheroids (modified from ^[@R15]^). We adapted each protocol to growth in spinner-flask bioreactors over durations of at least 6 months, to achieve advanced maturation ([Extended Data Fig. 1a](#F5){ref-type="fig"}; see Methods for details on protocol modifications).

To standardize and compare these four models, we derived cultures of each from the same hiPSC line, PGP1^[@R16]^. We observed substantial differences in overall external morphology and size across models ([Extended Data Fig. 1a](#F5){ref-type="fig"}). Self-patterned whole-brain organoids showed the greatest variability in shape. The two patterned spheroid models showed more consistent shape but remained substantially smaller. The dorsally patterned organoid model, however, showed desirable features of large size and consistent overall shape ([Fig. 1a](#F1){ref-type="fig"}--[b](#F1){ref-type="fig"} and [Extended Data Fig. 1a](#F5){ref-type="fig"}). For this model, we modified the protocol originally published by Kadoshima *et al.*^[@R5]^ to eliminate the need for interventions to reduce hypoxia by adapting the cultures to growth in spinner-flask bioreactors ([Fig. 1a](#F1){ref-type="fig"}), allowing us to substantially extend development *in vitro* ([Extended Data Fig. 1a](#F5){ref-type="fig"}). Immunohistochemistry (IHC) for the dorsal forebrain progenitor markers EMX1 and PAX6 and for the early pan-neuronal marker MAP2 confirmed the presence of rosette-like structures at one month, when dorsalized progenitors lined ventricle-like cavities. The cortical pyramidal neuron subtype markers CTIP2 and SATB2 were expressed by 3 months and subsequently maintained ([Fig. 1c](#F1){ref-type="fig"} and [Extended Data Fig. 1b](#F5){ref-type="fig"}). Importantly, we observed these features in the majority of organoids across 5 distinct stem cell lines: PGP1 (male, hiPSC; three independent experimental batches), HUES66 (female, hESC; two independent batches), GM08330 (male, hiPSC), 11a (male, hiPSC), and Mito 210 (male, hiPSC). Across all lines, 100% of organoids expressed PAX6 and MAP2 at 1, 3, and 6 months, and 89% also expressed EMX1 ([Extended Data Table 1](#T1){ref-type="table"}). Given these promising features, we concentrated further analysis on this model.

We initially performed high-throughput single cell RNA-seq (scRNA-seq) on 78,379 cells from 9 individual organoids from two stem cell lines, PGP1 (two independent batches, b1 and b2) and HUES66 (one batch), at 3 months of growth ([Fig. 1d](#F1){ref-type="fig"}). For each batch, we clustered cells from all organoids and systematically classified the clusters by comparing signatures of differentially expressed genes ([Supplementary Information Table 1](#SD2){ref-type="supplementary-material"}, [Supplementary Information Note 1](#SD2){ref-type="supplementary-material"}) to pre-existing datasets of endogenous cell types^[@R3],[@R8],[@R17]--[@R23]^ (examples in [Extended Data Fig. 2a](#F6){ref-type="fig"}). This defined eleven main transcriptionally-distinct cell types across both lines, representing a large diversity of progenitor and neuronal types appropriate for the cerebral cortex ([Fig. 1d](#F1){ref-type="fig"}).

To determine whether each organoid had generated the complete set of cells, we aligned and co-clustered the cells from all 9 organoids ([Fig. 1d](#F1){ref-type="fig"}). We found that organoids were highly reproducible in cellular composition across different lines and batches ([Fig. 1d](#F1){ref-type="fig"}). Furthermore, the cell type assignments from the batch-by-batch analysis were grouped together by the co-clustering analysis, indicating consistent transcriptional signatures for individual cell types across lines and batches. Although one organoid (Org 4) had an increased number of corticofugal projection neurons, the overall proportions of individual cell types were consistent across cell lines (see also [Extended Data Fig. 5A](#F9){ref-type="fig"}). Expression of cell type-specific markers assayed by IHC and RNA *in situ* hybridization showed equally high consistency ([Extended Data Fig. 2b](#F6){ref-type="fig"}--[d](#F6){ref-type="fig"}). These organoids not only produce a large variety of cortical cell types, but cell identity and diversity are reproducible organoid-to-organoid and across experiments.

Cellular diversity of the cerebral cortex develops in a specific temporal sequence^[@R23],[@R24]^. Astroglial cells, which are typically produced later in development, were notably under-represented in the 3-month cultures. Therefore, we grew organoids from the PGP1, GM08330, and 11a stem cell lines for six months and performed scRNA-seq of an additional 87,863 cells from 12 individual organoids (PGP1: two independent batches, b1 and b3; GM08330 and 11a: one batch) ([Fig. 2a](#F2){ref-type="fig"}). One out of the 12 organoids did not show expression of *FOXG1* or any other neuronal marker, suggesting that differentiation had stalled at an early stage. Therefore, we excluded this organoid from further analysis. Co-clustering of all cells in the remaining 11 organoids identified thirteen main cell classes ([Fig. 2a](#F2){ref-type="fig"}). Importantly, organoid-to-organoid variability remained extremely low even after 6 months of culture.

To quantify changes in cellular composition over time, we combined and co-clustered cells from organoids derived from the same differentiation batch (PGP1 b1) but collected at 3 and 6 months ([Fig. 2b](#F2){ref-type="fig"}). The six-month cultures contained substantial numbers of astrocytes, confirmed by IHC for the astrocytic markers S100B and GFAP ([Fig. 2c](#F2){ref-type="fig"}), as well as cycling inhibitory interneuron precursors and immature inhibitory interneurons ([Fig. 2a](#F2){ref-type="fig"}--[b](#F2){ref-type="fig"}). While the origin of these interneurons is unclear, their transcriptional similarity to IPCs (see also [Extended Data Fig. 4b](#F8){ref-type="fig"}) suggests that they could be interneurons of the olfactory bulb, which originate from subventricular zone progenitors^[@R25]^. The data indicate that appropriate additional cell types develop in these organoids, respecting endogenous temporal sequences. Despite the long culture period, molecular markers of apoptosis and hypoxia remained low ([Extended Data Fig. 3a](#F7){ref-type="fig"}--[e](#F7){ref-type="fig"}).

It is possible that, within individual organoids, the same terminal composition of cell types may be generated via distinct developmental trajectories. Therefore, we calculated a developmental pseudotime trajectory^[@R26]^ across all cell lines for each timepoint. Each organoid distributed similarly along the pseudotime trajectory, independent of line or batch, and the pseudotemporal ordering of cell types approximated that of *in vivo* human development ([Fig. 3a](#F3){ref-type="fig"}--[b](#F3){ref-type="fig"} and [Extended Data Fig. 4a](#F8){ref-type="fig"}). At three months, all organoids followed a trajectory that progressed from radial glia to mature excitatory neurons. Confirming neuronal maturation, colocalization of the pre- and post-synaptic markers VGluT1 and PSD95 suggested the presence of excitatory synapses at this timepoint ([Fig. 3c](#F3){ref-type="fig"}). At six months, the trajectory proceeded along two branches, towards excitatory neurons or mature astrocytes. The data indicate that beyond terminal cellular composition, developmental trajectories of fate specification are reproducibly established in each organoid and therefore can be reliably investigated in this system.

To assess similarity between organoid cell types and those of the endogenous human brain, we employed a published scRNA-seq dataset of human fetal cerebral cortex^[@R18]^. Briefly, fetal human cells were used to train a Random Forest classifier, which was then applied to assign organoid cells to the human cortex cell categories^[@R27]^. Organoid cells at both 3 and 6 months were predominantly assigned to the corresponding endogenous cell class, indicating that their transcriptional profiles were similar to endogenous cells ([Fig. 3d](#F3){ref-type="fig"} and [Extended Data Fig. 4b](#F8){ref-type="fig"}). Importantly, the main cell types present in organoids at 3 months are as similar to the corresponding endogenous cells as those present at 6 months, suggesting that by 3 months organoids are already a valuable tool for modeling human neurodevelopmental processes.

It is unclear whether treatment with exogenous patterning signals may negatively affect the fidelity of terminal cell identities. Therefore, we investigated whether transcriptional similarity to endogenous human fetal cortex^[@R18]^ cells was comparable to that found in self-patterned whole-brain organoids analyzed in our previous study^[@R3]^ (see Methods). All of the dorsally patterned organoids and the whole-brain organoids showed similarly high correlation with human cells (correlation coefficients between 0.67 and 0.80; [Fig. 3e](#F3){ref-type="fig"}). Therefore, the use of exogenous patterning signals in this model does not require a trade-off in the fidelity of the cell types generated.

To evaluate the reproducibility of this model relative to prior systems, we compared the variability of dorsally patterned forebrain organoids and self-patterned whole-brain organoids^[@R3]^ ([Fig. 4a](#F4){ref-type="fig"},[b](#F4){ref-type="fig"} and [Extended Data Fig. 5a](#F9){ref-type="fig"},[b](#F9){ref-type="fig"}). scRNA-seq data for the 19 individual self-patterned whole-brain organoids in our previous study^[@R3]^ showed high organoid-to-organoid variability, with only a minority of organoids (4/19) generating substantial amounts of forebrain cells ([Extended Data Fig. 5b](#F9){ref-type="fig"}). We applied intraclass correlation (ICC), a correlation metric that considers group structure in the data (i.e., cell types), to the proportions of each cell type produced by each organoid; an ICC near 1.0 indicates high agreement. The 19 organoids in the whole-brain organoid cohort had an ICC of 0.39 (95% Confidence Interval \[CI\] 0.23--0.65). In contrast, the pre-patterned organoids of the present study scored much higher (3 month organoids: ICC 0.85, 95% CI: 0.69--0.96; 6 month organoids: ICC 0.68, 95% CI: 0.45--0.89) ([Extended Data Fig. 5a](#F9){ref-type="fig"}).

The availability of single-cell RNA-seq datasets from individual human^[@R28],[@R29]^ and mouse^[@R30]^ cortices allowed us to investigate if the reproducibility of cell types generated in dorsally patterned organoids was similar to that of endogenous brains. As existing datasets vary in the terminology and degree of granularity used for cell type assignment ([Extended Data Fig. 5](#F9){ref-type="fig"}), we first re-clustered each dataset using identical methods. We calculated mutual information (MI) scores between cluster assignments and sample identity in each dataset ([Fig. 4a](#F4){ref-type="fig"}--[e](#F4){ref-type="fig"}); a lower MI score and lower z-score indicate higher reproducibility between individuals. For the self-patterned whole-brain organoid model^[@R3]^, we examined specifically the best performing batch of 4 organoids that produced forebrain cells; these organoids had a high MI score of 0.27 and a z-score of 156.4 ([Fig. 4b](#F4){ref-type="fig"}). Conversely, in the dorsally patterned organoids, reproducibility was consistently high, as reflected in low MI and z-scores (MI 0.049--0.089, z-score 38.0--75.7) ([Fig. 4a](#F4){ref-type="fig"}). Remarkably, the reproducibility with which the different clusters are generated in individual dorsally patterned organoids ([Fig. 4a](#F4){ref-type="fig"} and [Extended Fig. 5a](#F9){ref-type="fig"}) is comparable to that of individual endogenous human or mouse brain samples (MI range 0.008--0.064, z-score range 2.2--41.4) ([Fig. 4c](#F4){ref-type="fig"}--[e](#F4){ref-type="fig"} and [Extended Data Fig. 5c](#F9){ref-type="fig"}--[e](#F9){ref-type="fig"}). All datasets, including the human and mouse endogenous brains, showed variation between samples; however, the degree of variation in the dorsally patterned organoid samples was similar to that of the endogenous brain datasets.

Stem cell-based models of the human brain offer an opportunity to investigate processes of human brain development and disease that would not otherwise be experimentally accessible. However, their application has been limited by a variety of factors, prime among which is the lack of developmental reproducibility between individual organoids. Here, through the largest-to-date scRNA-seq dataset in brain organoids, we demonstrate that extensive cellular diversity of a complex CNS region can be generated outside of the embryo in a highly reproducible and developmentally-constrained manner that transcends individual organoids, experimental batch, genetic background, and sex. These data suggest that dynamic processes of development can be modeled in organoids, and that early patterning of a brain region starts a process of cell specification and maturation that is highly constrained even outside the embryo. This level of reproducibility *in vitro* informs us about basic constraints and principles that control cell diversification in the human brain, and establishes a valuable organoid model amenable to the experimental investigation of developmental abnormalities associated with human neurological disease that would otherwise not be experimentally accessible.

Methods {#S1}
=======

Pluripotent stem cell (PSC) culture. {#S2}
------------------------------------

The PGP1 (Personal Genome Project 1) hiPSC line was from the lab of George Church^[@R16]^; the HUES66 hESC and the 11a hiPSC lines from the Harvard Stem Cell Institute; the GM08330 hiPSC line^[@R31]^ (also known as GM8330--8)^[@R32]^ from the lab of Michael Talkowski (MGH Hospital); and the Mito 210 hiPSC line from the lab of Bruce Cohen (McLean Hospital). All PSC lines were cultured in feeder-free conditions on Geltrex (Gibco)-coated cell culture dishes, using mTESR1 medium (Stem Cell Technologies) with 100 U/mL penicillin and 100 μg/mL streptomycin (Corning), at 37˚C in 5% CO~2~. All human PSCs were maintained below passage 50, were negative for mycoplasma (assayed with the MycoAlert™ PLUS Mycoplasma Detection Kit, Lonza), and karyotypically normal (G-banded Karyotype test, performed by WiCell Research Institute, Inc.).

Organoid differentiation. {#S3}
-------------------------

To generate dorsally patterned forebrain organoids, we modified the method previously described in Kadoshima *et al.*^[@R3]^. We eliminated the need for growth under 40% O~2~, the need for cell aggregates to be periodically bisected, and the use of high O~2~ penetration dishes, by adapting the cultures to growth in spinner-flask bioreactors. Specifically, on day 0, feeder-free cultured human PSCs, 80--90% confluent, were dissociated to single cells with Accutase (Gibco), and 9,000 cells per well were reaggregated in ultra-low cell-adhesion 96-well plates with V-bottomed conical wells (sBio PrimeSurface plate; Sumitomo Bakelite) in Cortical Differentiation Medium (CDM) I, containing Glasgow-MEM (Gibco), 20% Knockout Serum Replacement (Gibco), 0.1 mM Minimum Essential Medium non-essential amino acids (MEM-NEAA) (Gibco), 1 mM pyruvate (Gibco), 0.1 mM 2-mercaptoethanol (Gibco), 100 U/mL penicillin, and 100 μg/mL streptomycin (Corning). From day 0 to day 6, ROCK inhibitor Y-27632 (Millipore) was added to the medium at a final concentration of 20 μM. From day 0 to day 18, Wnt inhibitor IWR1 (Calbiochem) and TGFβ inhibitor SB431542 (Stem Cell Technologies) were added at a concentration of 3 μM and 5 μM, respectively. From day 18, the floating aggregates were cultured in ultra-low attachment culture dishes (Corning) under orbital agitation (70 rpm) in CDM II, containing DMEM/F12 medium (Gibco), 2mM Glutamax (Gibco), 1% N2 (Gibco), 1% Chemically Defined Lipid Concentrate (Gibco), 0.25 μg/mL fungizone (Gibco), 100 U/mL penicillin, and 100 μg/mL streptomycin. On day 35, cell aggregates were transferred to spinner-flask bioreactors (Corning) and maintained at 56 rpm, in CDM III, consisting of CDM II supplemented with 10% fetal bovine serum (FBS) (GE-Healthcare), 5 μg/mL heparin (Sigma), and 1% Matrigel (Corning). From day 70, organoids were cultured in CDM IV, consisting of CDM III supplemented with B27 supplement (Gibco) and 2% Matrigel. A step-by-step protocol describing the long-term culture of dorsally patterned forebrain organoids is available at [Protocol Exchange](#SD4){ref-type="supplementary-material"}^[@R33]^. Over the time course of the differentiations (experimental batches) included in this paper, an estimated 13 batches of FBS, 4 batches of KSR, and 23 batches of Matrigel were used.

We observed that when starting with healthy viable hiPSCs (mycoplasma-free, karyotypically normal and below passage 50) with typical morphological features of undifferentiated cells (tightly packed colonies of round cells with large nuclei and nucleoli) at 80--90% confluency, the efficiency of forebrain cell type generation was \~90% (93/103 organoids, single-cell RNA-seq and IHC combined efficiency, [Extended Data Table 1](#T1){ref-type="table"}).

Self-patterned whole-brain organoids were generated as previously described^[@R3],[@R34]^. Dorsal and ventral spheroids were generated using a modification of a previously described protocol^[@R15]^. Specifically, spheres of pluripotent stem cells were grown for four additional days before neural induction; for ventral spheroids, specification of ventral telencephalic identity was obtained by treatment with the SHH agonist SAG (Selleckhem; 100nM) from days 7 to 20.

Immunohistochemistry and *In Situ* Hybridization. {#S4}
-------------------------------------------------

Samples were fixed in 4% paraformaldehyde (Electron Microscopy Services), cryoprotected in 30% sucrose solution, embedded in Optimum Cutting Temperature (OCT) compound (Tissue Tek) and cryosectioned (14 μm thickness). Sections were washed with 0.1% TWEEN-20 (Sigma) in Phosphate buffered saline (PBS) (Gibco), blocked for 1 hr at RT with 6% donkey serum (DS) (Sigma) + 0.3% Triton X-100 (Sigma) in PBS, and incubated with primary antibodies overnight at 4℃ (diluted with 2.5% DS + 0.1% Triton X-100 in PBS). Primary antibodies and dilutions used are specified in [Extended Data Table 2](#T2){ref-type="table"}. PSD95 and VGluT1 immunohistochemistry (IHC) was performed as in Arlotta *et al*.^[@R20]^. RNA *in situ* hybridization was performed using the RNAscope Fluorescent Multiplex Reagent Kit (Advanced Cell Diagnostics) according to the manufacturer's instructions. The probes used are: Hs-EOMES-C2 (429691-C2), Hs-TBR1-C3 (425571-C3), and Hs-Reln (413051) (Advanced Cell Diagnostics).

Microscopy and Image analysis. {#S5}
------------------------------

Images of organoids in culture were taken on an EVOS FL microscope (Invitrogen). Immunofluorescence images were obtained using an LSM 700 inverted confocal microscope (Zeiss) and analyzed with the ZEN Blue/Black 2012 image-processing software.

Dissociation of brain organoids and single-cell RNA-seq. {#S6}
--------------------------------------------------------

Individual brain organoids were dissociated into a single-cell suspension using the Worthington Papain Dissociation System kit (Worthington Biochemical). A detailed description of the dissociation protocol is available at [Protocol Exchange](#SD4){ref-type="supplementary-material"}^[@R33]^. Dissociated cells were resuspended in ice-cold PBS containing 0.04% BSA (Sigma) at a concentration of 1000 cells/μL, and approximately 17,400 cells per channel (to give estimated recovery of 10,000 cells per channel) were loaded onto a Chromium™ Single Cell 3' Chip (10x Genomics, PN-120236) and processed through the Chromium Controller to generate single-cell GEMs (Gel Beads in Emulsion). Single-cell RNA-Seq libraries were prepared with the Chromium™ Single Cell 3' Library & Gel Bead Kit v2 (10x Genomics, PN-120237). Libraries from different samples were pooled based on molar concentrations and sequenced on a NextSeq 500 instrument (Illumina) with 26 bases for read 1, 57 bases for read 2 and 8 bases for Index 1. After the first round of sequencing, libraries were re-pooled based on the actual number of cells in each and re-sequenced to give equal number of reads per cell in each sample and to reach a sequencing saturation of at least 50% (in most cases \>70%).

Single-cell RNA-seq data analysis. {#S7}
----------------------------------

The Cell Ranger 2.0.1 pipeline (10x Genomics)^[@R35]^ was used to align reads from RNA-seq to the GRCh38 human reference genome and produce the associated cell by gene count matrix [(Extended Data Table 3)](#T3){ref-type="table"}. Default parameters were used, except for the '\--cells' argument. Unique Molecular Identifier (UMI) counts were analyzed using the Seurat R package v2.3.4^[@R36]^. Cells expressing a minimum of 500 genes were kept, and UMI counts were normalized for each cell by the total expression, multiplied by 1 million, and log-transformed. Seurat's default method for identifying variable genes was used with x.low.cutoff=1, and the ScaleData function was used to regress out variation due to differences in total UMIs per cell. Principal component analysis (PCA) was performed on the scaled data for the variable genes, and significant principal components (PC) were chosen. Cells were clustered in PCA space with a method adapted from ^[@R27]^ by finding the 50 nearest neighbors to each cell using R's RANN package^[@R37]^, building a graph with edges between neighbor cells weighted by the Jaccard distance, and performing Louvain clustering on the resulting graph. Variation in the cells was visualized by t-SNE on the significant PCs.

For each dataset of three organoids, differentially expressed genes upregulated in each cluster compared to the rest of the cells were identified using Seurat's implementation of the Model-based Analysis of Single Cell Transcriptomics (MAST) algorithm^[@R38]^ ([Supplementary Information Table 1](#SD2){ref-type="supplementary-material"}). To identify cell types, genes with a Bonferroni-adjusted p value less than 0.01 and a log Fold Change of at least 0.25 were taken into consideration. Ambient RNA was found to affect clustering distribution in at least two individual batches ([Supplementary Note 1](#SD2){ref-type="supplementary-material"}), but no correction was needed after comparing data across batches. To do so, we used Seurat's canonical correlation analysis (multi-CCA) procedure for batch correction with default parameters^[@R36]^. Briefly, this identifies vectors along which the datasets correlate, and then aligns values along these vectors to reduce batch variation. T-SNE plots were used to visualize variation in the data after alignment in the top 20 canonical correlation vectors.

Pseudotime analysis was performed using the Monocle package v2.99.1^[@R26]^ with default parameters. UMI counts from 35,000 randomly sampled cells per timepoint were imported into Monocle's CellDataSet object with an expected negative binomial distribution. T-SNE plots were used for visualization, and the "SimplePPT" method was employed to learn a tree-like trajectory between the cells. When ordering the cells along this trajectory, cells previously assigned to the "Cycling Progenitors" cell type were specified as the starting state. Finally, Scrublet v0.1^[@R39]^ was used to assess the effect of droplets that may have contained more than one cell, with an expected doublet rate of 0.1 and a score threshold of 0.39, chosen based on histograms of simulated doublet scores ([Extended Data Fig. 3F](#F7){ref-type="fig"}).

Comparison to published single-cell RNA-seq data. {#S8}
-------------------------------------------------

To compare the cell types found in the dorsally patterned organoids to previously published data from whole-brain organoids^[@R3]^ and endogenous tissue^[@R18],[@R28]--[@R30]^, we downloaded UMI count data available from those publications, created Seurat objects, and submitted it to the same normalization, clustering, and visualization pipeline as above. In the case of Fan *et al*.,^[@R29]^ log(TPM+1) were used instead of UMI counts. To compare variability in cell type proportion between dorsally patterned organoids and whole-brain organoids, intraclass correlation was computed by creating a table of cell type proportions across each individual organoid, and using the icc command in the irr R package v0.84, with model="twoway", type="agreement", and unit="single". To compare cell type classifications between organoid data and fetal human data (as in [Fig. 4A](#F4){ref-type="fig"} and [Extended Data Fig. 5A](#F9){ref-type="fig"}), cell types as assigned to each cell by Nowakowski *et al.*^[@R18]^ were aggregated into more general cell types (after removing clusters not found in organoids: oligodendrocyte precursors, endothelial, and microglia, or with too few cells: unknown and astrocytes) and used to train a Random Forest classifier to distinguish between cell types^[@R27]^. This was done with the tuneRF function in the randomForest R package^[@R40]^ with doBest=T, after the data was downsampled to 314 cells per cell type (the size of the smallest cell type). The classifier was then applied to the organoid data to assign organoid cells to one of the human cortex cell types. To calculate correlations between cell types (as in [Fig. 3e](#F3){ref-type="fig"}), we assigned cell types to cells in Nowakowski *et al*.^[@R18]^ using the same method that was used for organoids. The Spearman correlation was calculated between the gene expression of highly variable genes in the Nowakowski *et al*.^[@R18]^ dataset in the "average cell" in each cell type (calculated with Seurat's AverageExpression function). To measure reproducibility of clusters per individual organoid, human cortex, or mouse cortex sample, data was downsampled to have 659 cells per individual (to match the sample with the fewest cells, adult human cortex 5) before clustering all individuals in a dataset together. Mutual information was calculated between cluster assignments and individuals with the mpmi R package. Z-scores were calculated by creating background distributions for each dataset, by permuting cluster assignments and re-calculating the mutual information score 1,000 times.

Statistics and Reproducibility. {#S9}
-------------------------------

A total of 21 single organoids collected at 3 and 6 months, derived from 4 different cell lines, from 6 independent batches (PGP1: 3 batches; HUES66, GM08330, and 11a: 1 batch each; n=3 organoids per batch and timepoint) were profiled by single-cell RNA-seq. Analysis of over 166,242 single cells revealed reproducibility in the diversity of cell types generated "organoid-to-organoid" for 20/21 organoids (\~95% efficiency) ([Extended Data Table 1](#T1){ref-type="table"}). A total of 82 single organoids, derived from 5 different lines, from 8 independent batches (PGP1: 3 batches; HUES66: 2 batches; GM08330, 11a, and Mito 210: 1 batch each) were analyzed by IHC for expression of EMX1, PAX6, MAP2 at 1 month (n=26/26 positive); 3 months (n=37/37 positive for PAX6 and MAP2; and 36/37 positive for EMX1); and 6 months (n=19/19 positive for PAX6 and MAP2; 11/19 positive for EMX1) ([Fig. 1c](#F1){ref-type="fig"}, [Extended Data Fig. 2b](#F6){ref-type="fig"}, and [Extended Data Table 1](#T1){ref-type="table"}). IHC for CTIP2 and SATB2 was performed on 3 month organoids derived from 5 different cell lines, from 8 independent batches (PGP1: 3 batches; HUES66: 2 batches; GM08330, 11a, and Mito 210: 1 batch each) (n=32/37 positive) ([Fig. 1c](#F1){ref-type="fig"}, [Extended Data Fig. 2b](#F6){ref-type="fig"}). IHC for GFAP and S100B ([Fig. 2c](#F2){ref-type="fig"}) was performed on 6 month organoids derived from 1 cell line (PGP1, 1 batch) (n=3/3 positive). IHC for VGluT1 and PSD95 ([Fig. 3c](#F3){ref-type="fig"}) was performed on 3 month organoids from 2 cell lines, from 2 independent batches (PGP1 and 11a: 1 batch each) (n=8/8 positive). IHC for SOX2 ([Extended Data Fig. 2b](#F6){ref-type="fig"}) was performed on 3 month organoids from 5 cell lines, from 7 batches (PGP1: 2 batches; HUES66: 2 batches; 11a, GM08330, and Mito210: 1 batch) (n=34/34 positive). IHC for Ki67 ([Extended Data Fig. 2b](#F6){ref-type="fig"}) was performed on 3 month organoids from 4 cell lines, from 4 batches (PGP1, 11a, HUES66, and GM08330: 1 batch each) (n=22/22 positive). IHC for FOXG1, HOPX, TBR1, and TBR2 at 3 months and 6 months ([Extended Data Fig. 2d](#F6){ref-type="fig"}) was performed on organoids from one cell line (PGP1: 1 batch) (n=7/7 positive). IHC for HOPX at 3 months was also performed on two additional cell lines (HUES66 and GM08330: 1 batch each) (n=12/12 positive). IHC for cleaved Caspase 3 ([Extended Data Fig. 3e](#F7){ref-type="fig"}) was performed on organoids from one batch of the PGP1 cell line, at 3, 4, 5 and 6 months (n=3 for each timepoint). Overall, expression of MAP2, EMX1, PAX6, CTIP2, and SATB2 was assessed at 1, 3 and 6 months on organoids from each independent batch, and at 2, 4 and 5 months for one batch of PGP1 ([Extended Data Fig. 1b](#F5){ref-type="fig"}).

RNA in situ Hybridization for EOMES (TBR2), Reelin, and TBR1 was performed on 3 month organoids from 4 cell lines (PGP1, 11a, GM08330, HUES66), from 4 batches (n=22/22 positive). No statistical methods were used to predetermine the sample size.

Data availability. {#S10}
------------------

Single-cell RNA-seq data that support the findings of this study have been deposited at Gene Expression Omnibus, accession number GSE129519, and at the Single Cell Portal ([portals.broadinstitute.org/single_cell/study/reproducible-brain-organoids](https://portals.broadinstitute.org/single_cell/study/reproducible-brain-organoids)). The reference datasets used for comparison are available in the Gene Expression Omnibus at accession numbers GSE86153, GSE116470, and GSE103723, or in dbGaP at accession phs000989.v3, and phs000424.v8.p1.

Code availability. {#S11}
------------------

The code used for data analysis is available on GitHub (<https://github.com/AmandaKedaigle/BrainOrganoidsReproducibility>).

Extended Data {#S12}
=============

![Comparison of organoids and spheroids generated by different protocols.\
**a,** From left: self-patterned whole-brain organoids^[@R3]^, dorsally patterned forebrain organoids (protocol modified from Kadoshima *et al*.^[@R5]^), and dorsal and ventral forebrain spheroids (protocol modified from Rigamonti *et al*.^[@R15]^). All models are generated from the PGP1 line and cultured for 6 months. **b,** IHC for neuronal (MAP2), dorsal forebrain progenitor (EMX1 and PAX6), CFuPN (CTIP2), and CPN (SATB2) markers, across a time course from 1 to 6 months \[scale bars: whole organoids (Whole Org), left column, 200μm; close-up images, 50μm\].](nihms-1529307-f0005){#F5}

![Analysis of cell type-specific markers in organoids derived from different lines.\
**a,** Expression of selected marker genes used in cell type identification. Violin plots show distribution of normalized expression in cells from CCA-aligned organoids at 3 months (n=9 organoids from 3 batches). CFuPNS: n=15,866 cells; CPNs, n=18,905 cells; Cycling, n=4,035 cells; Immature INs, n=353 cells; Immature PNs, n=6,727 cells; IPCs, 4,276 cells; oRG, n=5,436 cells; and RG, n=3,318 cells. Scale: normalized read counts. **b,** IHC for neuronal (MAP2), dorsal forebrain progenitor (EMX1 and PAX6), CFuPN (CTIP2), CPN (SATB2), radial glia (SOX2), and proliferation (Ki67) markers in PGP1 (b2), 11a, GM08330, and HUES66 organoids at 3 months. **c,** *In situ* RNA hybridization for the IPC (EOMES a.k.a. TBR2), Cajal-Retzius (Reelin), and post-mitotic PN (TBR1) markers in 3 month PGP1 (b2), 11a, GM08330, and HUES66 organoids. **d,** IHC for the forebrain progenitor (FOXG1), outer radial glia (HOPX), post-mitotic PN (TBR1), and IPC (TBR2) markers in PGP1 (b2) organoids at 3 and 6 months (scale bars for B, C, D: 50 μm). Abbreviations as in [Figure 1](#F1){ref-type="fig"}.](nihms-1529307-f0006){#F6}

![Evaluation of apoptosis, hypoxia, and doublets in organoid scRNA-seq data.\
**a-b,** T-SNE plots showing average scaled expression of all genes from the **a,** apoptosis and **b,** hypoxia mSigDB Hallmark genesets in PGP1 (b1) organoids at 3 (left) and 6 (right) months. Abbreviations as in [Figure 1](#F1){ref-type="fig"}. *n*=3 organoids per timepoint. **c-d,** Histograms showing number of cells expressing **c,** apoptosis markers and **d,** hypoxia markers in PGP1 organoids at 3 and 6 months. X-axis indicates average scaled expression of all genes in the corresponding mSigDB Hallmark geneset. The similarity in markers of hypoxia and apoptosis between the three and six month single-cell data indicates that the growth conditions of this protocol preserve the health of the tissue over many months in culture. **e,** IHC of a 6 month PGP1 organoid for the apoptotic marker activated caspase 3, on the perimeter (Box 1) and in the center of an organoid (Box 2) (scale bar: whole organoid section, 500 μm; close-up images, 100μm). **f,** Multiplet detection using the Scrublet^[@R39]^ program. Scores represent the probability that the "cell" represents a droplet containing more than one cell. From left, t-SNE plots of PGP1 (two batches: b1, b2; *n*=3 organoids for b1, and *n*=3 organoids for b2) and HUES66 (*n*=3 organoids) organoids at 3 months; and 11a (*n*=3 organoids), GM08330 (*n*=3 organoids), and PGP1 (two batches: b1, b3; *n*=3 organoids for b1, and *n*=2 organoids for b3) organoids at 6 months. Overall, 2-8% of cells were predicted to be multiplets, which is consistent with the expected multiplet rate (\~5%) given our loadings of approximately 10,000 cells per channel^[@R35]^.](nihms-1529307-f0007){#F7}

![Cell types in individual organoids are generated following a precise and reproducible temporal order and are transcriptionally similar to human fetal cortex cell types.\
**a,** T-SNE plots produced by Monocle2 showing the contribution of cells from individual PGP1 (b1) organoids at 3 (*n*=2,665, 3,094, and 2,264 cells from Orgs 1-3) and 6 months (*n*=3,959, 2,971, and 3,042 cells from Orgs 16-18) to plots in [Fig. 3a](#F3){ref-type="fig"}--[b](#F3){ref-type="fig"}. **b,** Agreement between cell type classifications in cell populations of 11a, GM08330, and PGP1 organoids (two batches: b1, b3) at 6 months with cell types described in a previously published single-cell RNA-seq dataset of the human fetal cortex^[@R18]^. Dot size and color intensity indicate the percent of organoid cells in each cell cluster assigned to each human cortex cell type by a Random Forest classifier. Abbreviations as in [Figure 1](#F1){ref-type="fig"}.](nihms-1529307-f0008){#F8}

![Dorsally patterned forebrain organoids show reproducibility similar to that of endogenous brain, as compared to self-patterned whole-brain organoids.\
a-b, Percent distribution of cell types in **a,** (left) individual 3 month PGP1 (two batches: b1, b2) and HUES66 (n=3 per batch) dorsally patterned forebrain organoids, and (right) individual 6 month 11a, GM08330, and PGP1 (two batches: b1, b3, n=3 per batch) dorsally patterned forebrain organoids, vs. **b,** individual 6 month self-patterned whole-brain organoids^[@R3]^. **c-e,** Distribution of cell types as assigned in the original publication across **c,** individual samples of fetal human cortex^[@R29]^, **d,** adult human cortex samples from distinct individuals^[@R28]^, and **e,** adult mouse cortex samples from distinct individuals^[@R30]^. Abbreviations as in [Fig. 1](#F1){ref-type="fig"}. DG, dentate gyrus; CGE, caudal ganglionic eminence; MGE, medial ganglionic eminence.](nihms-1529307-f0009){#F9}

###### Quantification of protocol efficiency.

Efficiency of dorsal forebrain cell type generation as assessed by IHC for neuronal (MAP2) and dorsal progenitor (PAX6 and EMX1) markers at 1, 3 and 6 months, and by single-cell RNA-seq analysis at 3 and 6 months. In addition to data for the 6 experimental batches described in this study, data for two additional batches, a replicate for the HUES66 and one batch for the additional line Mito 210, are also included in the table. Detailed information about repetitions and efficiency can be found in Methods, in the "Statistics and Reproducibility" section.

                              Expression of Neuronal and Cortical Markers by IHC   Generation of Forebrain Cell Types by RNA-seq                                                                
  ---------- ---------- ---- ---------------------------------------------------- ----------------------------------------------- ------- ------- ------- ------- ------ --------------- ------ ------
    1 Mo.       PGP1     2                            7                                                 7/7                        100%     7/7    100%     7/7    100%                         
     11a         1       4                           4/4                                               100%                         4/4    100%     4/4    100%                                 
   GM08330       1       6                           6/6                                               100%                         6/6    100%     6/6    100%                                 
   Mito 210      1       4                           4/4                                               100%                         4/4    100%     4/4    100%                                 
    HUES66       2       5                           5/5                                               100%                         5/5    100%     5/5    100%                                 
                                                                                                                                                                                                
               Total     7                            26                                               26/26                       100%    26/26   100%    26/26   100%                         
    3 Mo.       PGP1     3                            10                                               10/10                       100%    10/10   100%    9/10    90%    6 (2 batches)   6/6    100%
     11a         1       6                           6/6                                               100%                         6/6    100%     6/6    100%                                 
   GM08330       1       6                           6/6                                               100%                         6/6    100%     6/6    100%                                 
   Mito 210      1       3                           3/3                                               100%                         3/3    100%     3/3    100%                                 
    HUES66       2       12                         12/12                                              100%                        12/12   100%    12/12   100%     3          3/3        100%  
                                                                                                                                                                                                
    Total        8       37                         37/37                                              100%                        37/37   100%    36/37    97%     9          9/9        100%  
              Mito 210   1                            4                                                 4/4                        100%     4/4    100%     4/4    100%                         
    6 Mo.       PGP1     2                            6                                                 6/6                        100%     6/6    100%     5/6    83%    6 (2 batches)   5/6    83%
     11a         1       3                           3/3                                               100%                         3/3    100%     3/3    100%     3          3/3        100%  
   GM08330       1       3                           3/3                                               100%                         3/3    100%     3/3    100%     3          3/3        100%  
    HUES66       1       7                           7/7                                               100%                         7/7    100%     0/7     0%                                  
                                                                                                                                                                                                
    Total        5       19                         19/19                                              100%                        19/19   100%    11/19    58%     12        11/12       92%   
    Total        8       82                         82/82                                              100%                        82/82   100%    73/82    89%     21        20/21       95%   

###### 

Primary antibodies used for immunofluorescence.

   Primary Antibody       Host             Manufacturer           Catalog Number   Dilution
  ------------------- ------------ ----------------------------- ---------------- ----------
   Cleaved Caspase 3     Rabbit     Cell Signaling Technologies        9661         1/300
         CTIP2            Rat                  Abcam                 AB18465        1/100
         EMX1            Rabbit          Atlas Antibodies           HPA006421        1/50
         FOXG1           Rabbit                Abcam                  196868        1/100
         GFAP            Mouse             Sigma-Aldrich              G3893         1/400
         HOPX            Rabbit            Sigma-Aldrich            HPA030180      1/2,500
         Ki67            Mouse            BD Biosciences              550609        1/400
         MAP2           Chicken                Abcam                  AB5392       1/5,000
         PAX6            Rabbit              Biolegend                901301        1/400
         PSD95           Rabbit            Thermo Fisher             51-6900        1/350
         S100B           Rabbit                Abcam                 AB41548       1/2,000
         SATB2           Mouse                 Abcam                 AB51502         1/50
         SOX2             Goat              RD Systems                AF2018         1/50
         TBR1            Rabbit                Abcam                 AB31940        1/500
         TBR2            Rabbit              Millipore                AB2283       1/2,000
        VGluT1         Guinea Pig            Millipore                AB5905       1/2,000

###### Statistics from single-cell RNA-sequencing.

Columns 3-6 represent initial statistics reported from the CellRanger program, for consistency with prior studies; columns 7-9 represent final data after full quality control, as used in the analyses.

                                                   Total Reads   Mean Reads/Cell   Reads Mapped Confidently to Transcriptome   Median Genes/Cell   Cells Passing QC   Mean Mapped Reads in Passing Cells   Median Mapped Reads in Passing Cells
  ---------------- ---------------- ------------- ------------- ----------------- ------------------------------------------- ------------------- ------------------ ------------------------------------ --------------------------------------
       3 Mo.        PGP1 (batch 1)     Org \#1     282,380,462       47,610                         45.80%                           2,086              5,924                       17,915                                16,290
      Org \#2        308,237,385       44,847        47.00%           1,898                          6,858                          18,010              15,555                                            
      Org \#3        232,194,411       46,429        45.30%           2,055                          4,992                          17,926              15,485                                            
                                                                                                                                                                                                          
   PGP1 (batch 2)      Org \#4       320,293,451     35,627          48.80%                          2,078                           8,989              14,221                      12,146                
      Org \# 5       290,649,261       38,048        49.60%           1,988                          7,639                          15,012              11,545                                            
      Org \#6        312,301,428       28,326        49.00%           1,501                         11,018                          11,481              9,638                                             
                                                                                                                                                                                                          
       HUES66          Org \#7       357,410,387     33,993          53.90%                          1,741                          10,509              15,599                      13,346                
      Org \#8        360,164,748       35,362        52.70%           1,709                         10,175                          15,336              13,032                                            
      Org \#9        458,590,387       37,329        53.30%           1,589                         12,275                          17,141              15,263                                            
                                                                                                                                                                                                          
       6 Mo.             11a          Org \#10     328,096,843       35,504                         50.80%                           1,290              9,237                       14,958                                10,947
      Org \#11       309,099,766       36,343        52.00%           1,330                          8,495                          15,786              11,773                                            
      Org \#12       399,350,440       50,589        49.20%           1,438                          7,886                          20,607              15,158                                            
                                                                                                                                                                                                          
      GM08330          Org \#13      178,317,524     30,898          50.00%                          1,723                           5,759              11,255                      8,007                 
      Org \#14       175,558,635       32,271        49.60%           1,758                          5,436                          11,513              8,362                                             
      Org \#15       124,971,025       30,743        51.00%           1,724                          4,061                          10,635              7,485                                             
                                                                                                                                                                                                          
   PGP1 (batch 1)      Org \#16      420,342,563     49,850          52.50%                          1,477                           8,425              20,150                      14,760                
      Org \#17       300,940,886       47,496        52.80%           1,727                          6,327                          19,659              14,726                                            
      Org \#18       314,512,990       48,565        56.80%           1,501                          6,461                          22,105              16,655                                            
                                                                                                                                                                                                          
   PGP1 (batch 3)      Org \#19      249,698,784     30,376          50.60%                          1,472                           8,215              12,331                      9,489                 
      Org \#20       150,922,738       23,055        47.80%           1,581                          6,539                           9,253              7,102                                             
      Org \#21       347,029,455       31,479        58.00%           2,053                         11,022                          17,026              15,005                                            
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![Brain organoids cultured for 3 months generate cellular diversity of the human cerebral cortex with high organoid-to-organoid reproducibility.\
**a,** Protocol schematic. **b,** 3 month PGP1 (batch 1: b1) organoids. **c,** IHC of 1 month PGP1 (b1) organoids for neuronal (MAP2) and dorsal forebrain progenitor (EMX1) markers, and of 3 month PGP1 (b1) organoids for corticofugal projection neuron (CTIP2) and callosal projection neuron (SATB2) markers. Top, entire organoids (scale bar, 200 μm); bottom, high-magnification views of three different organoids per timepoint (scale bar, 50 μm). **d,** T-distributed stochastic neighbor embedding (t-SNE) plots of scRNA-seq data from 3 month organoids after canonical correlation analysis (CCA) batch correction and alignment (PGP1: two batches, b1, b2; HUES66: one batch, n=3 organoids per batch). Left column, combined organoids from each batch, colored by cell types; right, individual organoids. Number of cells per plot are indicated. PNs, projection neurons; CPNs, callosal PNs; IPCs, intermediate progenitor cells, CFuPNs, corticofugal PNs; INs, interneurons; RG, radial glia; oRG, outer radial glia; Imm., immature; Inhib., inhibitory. Information on replicates for all figures is reported in the Methods under "Statistics and Reproducibility".](nihms-1529307-f0001){#F1}

![Brain organoids cultured for 6 months show increased cortical cell diversity while maintaining high organoid-to-organoid reproducibility.\
**a,** T-SNE plots of combined 6 month organoids after batch correction (11a: one batch; GM08330: one batch; PGP1: two independent batches, b1, b3; n=3 organoids per batch). Left column, combined organoids from each batch, colored by cell type; right, individual organoids. Abbreviations as in [Figure 1](#F1){ref-type="fig"}. **b,** Left, t-SNE plots of PGP1 (b1) organoids at 3 and 6 months (n=3 organoids per timepoint) after batch correction. Right, percent distribution of cell types at each timepoint. **c,** IHC for astroglial markers GFAP and S100B in a PGP1 (b1) organoid at 6 months (scale bar: whole organoid, 500 μm; high-magnification, 100μm).](nihms-1529307-f0002){#F2}

![Cells in organoids are generated following a precise and reproducible trajectory and are transcriptionally similar to cells of the human fetal cortex.\
**a-b,** Pseudotime t-SNE plots for the 3 (**a**) and 6 (**b**) month organoids shown in [Figures 1d](#F1){ref-type="fig"} and [2a](#F2){ref-type="fig"}, colored according to cell type (far left) and pseudotime trajectory (center left; yellow-early to green-late). Right: contribution of each batch of organoids to the pseudotime plots. (n=3 organoids per batch, downsampled to 35,000 cells per timepoint.) **c,** Agreement between cell type classifications in the human fetal cortex^[@R18]^ and in cell populations of organoids at 3 months (n=3 organoids per batch). Dot size and color intensity indicate the percent of cells in each organoid cell type assigned to each human cell type by a Random Forest classifier. Abbreviations as in [Fig. 1](#F1){ref-type="fig"}. **d,** Spearman correlation coefficients of variable gene expression in human fetal cortex^[@R18]^ with equivalent cell types found in dorsally patterned forebrain organoids (n as in [Figures 1d](#F1){ref-type="fig"} and [2a](#F2){ref-type="fig"}) and self-patterned whole-brain organoids^[@R3]^ (n=19 individual organoids, 4 independent batches). **e,** IHC for neuronal (MAP2) and excitatory presynaptic (VGluT1) and postsynaptic (PSD95) markers in 3 month PGP1 and 11a dorsally patterned organoids; co-localization is shown in white (arrows) (scale bars: 20μm). Lower panels: VGluT1 and PSD95 staining alone; insets: enlargements of boxed areas.](nihms-1529307-f0003){#F3}

![Dorsally patterned organoids show sample-to-sample reproducibility similar to endogenous brains.\
**(a-e)** Percent of cells from each individual organoid or endogenous cortex belonging to each cell cluster in identically processed datasets from **a,** dorsally patterned forebrain organoids at 3 months (3 batches, n=9 organoids) and 6 months (4 batches, n=11 organoids), **b,** self-patterned whole-brain organoids at 6 months^[@R3]^ (n=4), **c,** fetal human cortex^[@R29]^ (n=2), **d,** adult human cortex^[@R28]^ (n=7), and **e,** adult mouse cortex^[@R30]^ (n=5). Top: t-SNE plots of the cell clusters for each dataset. Mutual information (MI) scores represent the dependence between the cluster and the individual (scores range from 0: individuals have the same cluster makeup, to 1: individuals cluster separately). Z-scores represent the divergence of the MI score from the mean MI score expected at random. All datasets downsampled to n=659 cells per sample.](nihms-1529307-f0004){#F4}
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